1-16 of 16
Authors: Clinton Stewart
Journal Article
PATH-13. MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT) Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii180, https://doi.org/10.1093/neuonc/noae165.0712
Published: 11 November 2024
Journal Article
MDB-65. RESULTS FROM THE SJ-ELIOT PHASE 1 CLINICAL TRIAL EVALUATING PREXASERTIB (LY2606368) IN COMBINATION WITH CYCLOPHOSPHAMIDE OR GEMCITABINE FOR CHILDREN AND ADOLESCENTS WITH REFRACTORY OR RECURRENT MEDULLOBLASTOMA Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.514
Published: 18 June 2024
Journal Article
CNSC-02. PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-056: A PHASE 1 STUDY OF THE ADAM-10 INHIBITOR, INCB007839, IN CHILDREN WITH RECURRENT/PROGRESSIVE HIGH-GRADE GLIOMAS TO TARGET MICROENVIRONMENTAL NEUROLOGIN-3 Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.035
Published: 18 June 2024
Journal Article
TRLS-16. RESULTS FROM SJDAWN: A ST JUDE CHILDREN’S RESEARCH HOSPITAL PHASE 1 STUDY EVALUATING MOLECULARLY DRIVEN DOUBLET THERAPIES FOR ALL CHILDREN WITH REFRACTORY OR RECURRENT CENTRAL NERVOUS SYSTEM (CNS) MALIGNANT NEOPLASMS AND YOUNG ADULTS WITH SHH MEDULLOBLASTOMA Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.169
Published: 18 June 2024
Journal Article
DIPG-54. UPDATED FINDINGS FROM THE PHASE IB STUDY OF UNESBULIN (PTC596) IN CHILDREN WITH NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT) Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i25–i26, https://doi.org/10.1093/neuonc/noad073.101
Published: 12 June 2023
Journal Article
MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i123–i124, https://doi.org/10.1093/neuonc/noac079.448
Published: 03 June 2022
Journal Article
EPCT-06. Phase I study of ribociclib and everolimus post-radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG): Updated report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT) Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i36–i37, https://doi.org/10.1093/neuonc/noac079.134
Published: 03 June 2022
Journal Article
EPCT-16. A PHASE IB STUDY OF PTC596 IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA AND HIGH GRADE GLIOMA Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii306–iii307, https://doi.org/10.1093/neuonc/noaa222.138
Published: 04 December 2020
Journal Article
EPCT-05. A PHASE I TRIAL OF THE CDK 4/6 INHIBITOR PALBOCICLIB IN PEDIATRIC PATIENTS WITH PROGRESSIVE OR REFRACTORY CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii304, https://doi.org/10.1093/neuonc/noaa222.129
Published: 04 December 2020
Journal Article
EPCT-19. A PHASE I STUDY OF RIBOCICLIB AND EVEROLIMUS FOLLOWING RADIATION THERAPY IN CHILDREN WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB+ BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG) Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii307, https://doi.org/10.1093/neuonc/noaa222.141
Published: 04 December 2020
Journal Article
CTNI-27. FIRST-IN-PEDIATRICS PHASE I STUDY OF GDC-0084 (PAXALISIB), A CNS-PENETRANT PI3K/mTOR INHIBITOR, IN NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR OTHER DIFFUSE MIDLINE GLIOMA (DMG) Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii48, https://doi.org/10.1093/neuonc/noaa215.194
Published: 09 November 2020
Journal Article
PDCT-10. FIRST IN PEDIATRICS PHASE I STUDY OF CRENOLANIB BESYLATE (CP-868,596-26) ADMINISTERED DURING AND AFTER RADIATION THERAPY (RT) IN NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND RECURRENT HIGH GRADE GLIOMA (HGG) Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi147–vi148, https://doi.org/10.1093/neuonc/now212.614
Published: 07 November 2016
Journal Article
PCM-06ACCURATE PRECLINICAL TRIALS OF NEW EPENDYMOMA THERAPIES Free
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii140, https://doi.org/10.1093/neuonc/now080.06
Published: 30 May 2016
Journal Article
MB-32MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE Free
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii104, https://doi.org/10.1093/neuonc/now076.30
Published: 30 May 2016
Journal Article
PCM-22A NEW APPROACH OF PRECLINICAL TESTING OF CHEMOTHERAPIES - AN EXAMPLE OF BRAIN TUMOUR THERAPY Free
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii144, https://doi.org/10.1093/neuonc/now080.22
Published: 30 May 2016
Journal Article
MB-19MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY Get access
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii24, https://doi.org/10.1093/neuonc/nov061.95
Published: 21 April 2015
